SERUM FERRITIN IN THALASSEMIC (MAJOR) PATIENTS WITH SUBCUTANEOUS DESFERAL VERSUS SUBCUTANEOUS AND INTRAVENOUS DESFERAL THERAPY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MIRBEHBAHANI N.B.; BESHARAT S.; JABARI ALI; MIR KATOULI N.; BEHNAMPOUR N.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pediatrics Year:2007 | Volume:17 | Issue:2 (SUPPLEMENT) Page(s): 249-254

Download Full-Text

Persian Verion

View:

1,554

Download:

Cites:

Information Journal Paper

Title

SERUM FERRITIN IN THALASSEMIC (MAJOR) PATIENTS WITH SUBCUTANEOUS DESFERAL VERSUS SUBCUTANEOUS AND INTRAVENOUS DESFERAL THERAPY

Author(s)

Keywords

SERUM FERRITINQ4

THALASSEMIAQ3

SUBCUTANEOUS DESFERALQ3

INTRAVENOUS DESFERALQ3

Abstract

Objective: b-thalassemia is a widespread disease. Long term transfusion is the most important therapy in these patients but the best regimen is controversial yet. In this study two groups of thalassemic patients were compared. SUBCUTANEOUS DESFERAL regimen was compared versus subcutaneous in combination with INTRAVENOUS DESFERAL. Material & Methods: This clinical trial was done on thalassemic patients in Pediatric Center who were similar in mean age, number of SUBCUTANEOUS DESFERAL infusions and number of transfusions. This study was done in one year and SERUM FERRITIN was measured every 3 months in patients (cases) and at the end of the study (in controls). Findings: Mean SERUM FERRITIN was significantly different in two groups at the end of the study (after one year follow-up), it was higher in case group than in controls (1.7 times) (P value=0.04).Conclusion: In this study, combination therapy of intravenous and SUBCUTANEOUS DESFERAL was more effective to reduce the iron overload. With more accurate management we will achieve a better long term prognosis in these patients.

Cites

No record.

References

No record.

Cite

APA: Copy

MIRBEHBAHANI, N.B., BESHARAT, S., JABARI, ALI, MIR KATOULI, N., & BEHNAMPOUR, N.. (2007). SERUM FERRITIN IN THALASSEMIC (MAJOR) PATIENTS WITH SUBCUTANEOUS DESFERAL VERSUS SUBCUTANEOUS AND INTRAVENOUS DESFERAL THERAPY. IRANIAN JOURNAL OF PEDIATRICS, 17(2 (SUPPLEMENT)), 249-254. SID. https://sid.ir/paper/76179/en

Vancouver: Copy

MIRBEHBAHANI N.B., BESHARAT S., JABARI ALI, MIR KATOULI N., BEHNAMPOUR N.. SERUM FERRITIN IN THALASSEMIC (MAJOR) PATIENTS WITH SUBCUTANEOUS DESFERAL VERSUS SUBCUTANEOUS AND INTRAVENOUS DESFERAL THERAPY. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2007;17(2 (SUPPLEMENT)):249-254. Available from: https://sid.ir/paper/76179/en

IEEE: Copy

N.B. MIRBEHBAHANI, S. BESHARAT, ALI JABARI, N. MIR KATOULI, and N. BEHNAMPOUR, “SERUM FERRITIN IN THALASSEMIC (MAJOR) PATIENTS WITH SUBCUTANEOUS DESFERAL VERSUS SUBCUTANEOUS AND INTRAVENOUS DESFERAL THERAPY,” IRANIAN JOURNAL OF PEDIATRICS, vol. 17, no. 2 (SUPPLEMENT), pp. 249–254, 2007, [Online]. Available: https://sid.ir/paper/76179/en

Related Journal Papers